Zdrowie i gospodarka · 15/08/1994

Premarket Approval of OPUSRegister CEA by PB Diagnostic Systems, Inc.

The Food and Drug Administration (FDA) approved the premarket application of PB Diagnostic Systems, Inc. for OPUS CEA on June 20, 1994, under section 515 of the Federal Food, Drug, and Cosmetic Act.